被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Bling Bling Sister BBS Superman Capsules contain the undeclared substances sibutramine and orlistat (English only) |
| |
The Therapeutic Goods Administration (TGA) announces that Bling Bling Sister BBS Superman capsules pose a serious risk to health and should not be taken. TGA has tested the product and found that the capsules contain the undeclared substances sibutramine and orlistat.
Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). Sibutramine was withdrawn from the Australian market in Oct 2010 after a study showed an increased risk of major cardiac events. Orlistat is a pharmacist-only medicine in Australia. Consumers are advised to stop taking Bling Bling Sister BBS Superman capsules and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/bling-bling-sister-bbs-superman-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Feb 26, 2020
Issued at HKT 15:00
|
| |
